ELMD News and Press, Electromed Inc. From 03/22/22

Digital health company Butterfly Network’s (BFLY) shares have plunged in price this year, closing the last trading session at $5.16. The stock is currently trading below its 50-day and 200-day moving averages. However, with the digital healthcare market growing rapidly, will the stock ...

The shares of biosensor diagnostic technology company GBS’s (GBS) have slumped more than 50% in price this year, reflecting investors’ pessimism. The company’s weak financial position seems to be overshadowing the company’s positive developments. So, will the penny...

The shares of commercial-stage medical device maker Ra Medical Systems (RMED) have tumbled 92.7% in price over the past year due to investor concerns surrounding the company’s poor financial health. Also, given the uncertainty surrounding the FDA’s approval of its DABRA catheter...

Key appointment will guide the Company’s strategic growth initiatives Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Chris...

Electromed, Inc. (ELMD) Q2 2022 Earnings Conference Call February 8, 2022 5:00 PM ET Company Participants Mike Cavanaugh - IR, ICR Westwicke Kathleen Skarvan - President & CEO Mike MacCourt - CFO Conference Call Participants Kyle Bauser - Colliers Securities Disclaimer*: This transcript i...

Electromed press release (NYSE:ELMD): Q2 GAAP EPS of $0.10 beats by $0.03. Revenue of $10.2M (+7.4% Y/Y) beats by $0.51M. For further details see: Electromed GAAP EPS of $0.10 beats by $0.03, revenue of $10.2M beats by $0.51M

Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced f...

The shares of respiratory support technology company Inspira Technologies (IINN) have declined in price considerably since its stock market debut. So, let's evaluate if it is worth betting on the stock now, given that the company is still in its early stages of development. Read on. Insp...

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on...

A global leader in medical technology, Medtronic’s (MDT) differentiated portfolio of medical devices and increased international market penetration have boosted investor confidence in the stock. Given the company’s robust revenue growth across all segments and the pent-up demand...